期刊文献+

加用拉莫三嗪治疗成人难治性部分性癫痫的疗效观察 被引量:10

Efficacy Observation of Lamotrigine Adjunctive Treatment for Adult Refractory Partial Epilepsy
原文传递
导出
摘要 目的:观察加用拉莫三嗪治疗难治性部分性癫痫的效果。方法:连续性收集2007-2010年在我院就诊的62例难治性部分性癫痫患者,均为连续正规治疗2年以上仍频繁发作的患者,原服用抗癫痫药药量不变,加用拉莫三嗪口服。采用开放性试验的方法观察6个月,评价拉莫三嗪对难治性部分性癫痫的发作控制率、脑电图改善情况、不良反应和安全性。结果:加用拉莫三嗪治疗难治性部分性癫痫,有效率82.3%,24.2%的患者发作完全控制。治疗前后的肝、肾、血、尿等实验室检查及心电图无明显变化,偶有患者出现轻度副作用,但不影响结果。结论:加用拉莫三嗪治疗难治性部分性癫痫疗效确切,副作用轻。 ABSTRACT OBJECTIVE: To observe the effect of lamotrigine adjunctive treatment for refractory partial epilepsy. METHODS: 62 cases of refractory partial epilepsy were continuously collected from our hospital from 2007 to 2010, and they received consecutive regular treatment for more than 2 years but still with frequent episodes. They were given the same dose of original antiepileptic drugs, and additionally received oral dose of lamotrigine. By open self-observation for 6 months, the control rate of lamotrigine to refractory partial epilepsy, the improvement of EEG, adverse drug reactions and safety were evaluated. RESULTS: After lamotrigine adjunctive therapy for refractory partial epilepsy, the effective rate was 82.3%, and 24.2% of patients were with complete control of seizures. The liver, kidney, blood, urine function and ECG had no significant changes before and after treatment. Occasionally patients had mild side effects, but it did not affect the results. CONCLUSION: Lamotrigine adjunctive therapy for refractory partial epilepsy is effective with slight side effects.
出处 《中国药房》 CAS CSCD 2012年第26期2451-2452,共2页 China Pharmacy
基金 昆山市2010年社会发展科技计划项目(KS1006、KS1009)
关键词 拉莫三嗪 丙戊酸钠 癫痫 Lamotrigine Valproate sodium Epilepsy
  • 相关文献

参考文献7

二级参考文献27

  • 1郑乃智,张慧娟,宋旭霞.拉莫三嗪添加治疗难治性癫癎的临床观察[J].临床神经电生理学杂志,2006,15(4):222-224. 被引量:15
  • 2BRODIE MJ, DUNCAN R, VESPIGNANI H, et al. Dosedependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures[J]. Epilepsia, 2006, 46( 1 ) : 31-41.
  • 3SACKELLARES JC, RAMSAY RE, WILDER BJ, et al. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures [J]. Epilepsia, 2004, 45(6) : 610-617.
  • 4MACDONALD RL. Mechanisms of action. In : LEVY RH, et al.eds. Antiepileptic drugs[M]. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2002: 867-872.
  • 5RAGUENEAU-MAJLESSI I, Lack of pharmacokinetic LEVY RH, BRODIE MJ, et al. interactions between steady-state zonisamide and valproic acid in patients with epilepsy [J]. Clin Phannacokinet, 2005, 44(5): 517-523.
  • 6LEVY RH, RAGUENEAU-MAJLESSI I, BRODIE MJ, et al. Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy[J]. Ther Drug Monit, 2005, 27(2): 193-198.
  • 7RAGUENEAU-MAJLESSI I, LEVY RH, BERGEN D, et al. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients[J]. Epilepsy Res, 2004, 62(1 ) : 1-11.
  • 8郭玉璞,王维治.神经病学[M].2版.北京:人民卫生出版社,2006:1047-1058.
  • 9Johannessen CU. Mechanisms of action of valproate: a commentatory [J]. Neurochem Int, 2000, 37(2): 103.
  • 10Duchowny M, Pellock JM, Crafwd, et al. Lamotrine add-ontherany for partial seizures in children [J]. Neurology, 1999,53(8) : 1724-1731.

共引文献37

同被引文献114

  • 1刘姜冰,石静萍,赵薛旭.托吡酯神经保护作用的研究进展[J].临床神经病学杂志,2005,18(4):317-318. 被引量:13
  • 2廖卫平,宋志彬,杨少青,蒲蜀湘,易咏红,赵绮华.拉莫三嗪治疗癫癎的有效性与剂量、血药浓度及合并用药关系的研究[J].中国神经精神疾病杂志,2005,31(6):438-441. 被引量:28
  • 3李世绰.中国六城市居民癫痫的流行病学调查[J].中华神经精神科杂志,1986,19(4):193-193.
  • 4Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: a positionpaper by the subcommission on therapeutic drug monitoring, ILAECommission on Therapeutic Strategies. Epilepsia,2008,49 ( 7 ):1239-1276.
  • 5Sondergaard KM,Nielsen KA,Dahl M,et al. Lamotrigine therapeu-tic thresholds. Seizure,2008,17(5) :391-395.
  • 6Contin M,Balboni M,Callegati E,et al. Simultaneous liquid chro-matographic determination of lamotrigine,oxcarbazepine monohy-droxy derivative and felbamate in plasma of patients with epilepsy.J Chromatogr B Analyt Technol Biomed Life Sci ’ 2005,828 (1-2):113-117.
  • 7Beck 0,Ohman I,Nordgren HK. Determination of lamotrigine andits metabolites in human plasma by liquid chromatography-massspectrometry. Ther Drug Monit, 2006,28(5) :603-607.
  • 8Johannessen SI. Can pharmacokinetic variability be controlled forthe patient's benefit the place of TDM for new AEDs. Ther DrugMonit,2005,27(6) :710-713.
  • 9Yamamoto Y,Inoue Y,Matsuda K,et al. Influence of concomitantantiepileptic drugs on plasma lamotrigine concentration in adultJapanese epilepsy patients. Biol Pharm Bull,2012,35 (4) :487-493.
  • 10Argikar UA,Remmel RP. Variation in glucuronidation of lamotrigi-ne in human liver microsomes. Xenobiotica, 2009,39 (5 ) :355-363.

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部